Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
UnitedHealth GroupUNH -0.89%78 Debt-to-EBITDA is 1.96 as of Mar. 2026, which is 8% above its 10-year median of 1.82. GuruFocus rates UNH with a GF Score™ of 78/100 and a GF Value™ of $604.56 (Significantly Undervalued). The stock has 9 warning signs investors should review. Among 13 Healthcare Plans companies, UnitedHealth Group ranks better than 53.85% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for UnitedHealth Group's Debt-to-EBITDA or its related term are showing as below:
UNH'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 1.7 Med: 1.82 Max: 3.41
Current: 3.41
During the past 13 years, the highest Debt-to-EBITDA Ratio of UnitedHealth Group was 3.41. The lowest was 1.70. And the median was 1.82.
UNH's Debt-to-EBITDA is ranked better than 53.85% of 13
companies
in the Healthcare Plans industry
Industry Median: 3.52
vs UNH: 3.41
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
UnitedHealth Group Debt-to-EBITDA Related Terms
UnitedHealth Group Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for UnitedHealth Group's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Healthcare Plans subindustry, UnitedHealth Group's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
UnitedHealth Group Debt-to-EBITDA vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, UnitedHealth Group's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where UnitedHealth Group's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
UnitedHealth Group (UNH) has a Debt-to-EBITDA of 1.96 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on UnitedHealth Group. This is near median its historical median of 1.82. Over the past decade, UnitedHealth Group's Debt-to-EBITDA has ranged from 1.70 to 3.41. According to the industry distribution chart, UnitedHealth Group ranks #6 out of 13 companies in the Healthcare Plans industry, placing it in the top 46.2%.
Is UnitedHealth Group's Debt-to-EBITDA too high?
UnitedHealth Group's current Debt-to-EBITDA of 1.96 is near median its 10-year median of 1.82. Over the past 10 years, this metric has ranged from a low of 1.70 to a high of 3.41. The Healthcare Plans industry median Debt-to-EBITDA is 3.52. UnitedHealth Group's value of 1.96 is 44.3% below this industry median. Based on the distribution chart, UnitedHealth Group ranks #6 out of 13 companies in the Healthcare Plans industry, which is above the industry midpoint. Overall, UnitedHealth Group has a GF Score™ of 78/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does UnitedHealth Group's Debt-to-EBITDA compare to CVS and ELV?
According to the Healthcare Plans industry distribution chart, UnitedHealth Group ranks #6 out of 13 companies for Debt-to-EBITDA. This puts UnitedHealth Group in the upper half of its industry. The industry median Debt-to-EBITDA is 3.52. UnitedHealth Group's value of 1.96 is 44.3% below this benchmark. Historically, UnitedHealth Group's own Debt-to-EBITDA has ranged from 1.70 to 3.41 over the past decade. While the company's 10-year median is 1.82 vs. the industry median of 3.52, UnitedHealth Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Plans company?
The median Debt-to-EBITDA among Healthcare Plans companies is 3.52, based on 13 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. UnitedHealth Group's current Debt-to-EBITDA of 1.96 is 44.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on UnitedHealth Group. For the Healthcare Plans industry, the median Debt-to-EBITDA is 3.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. UnitedHealth Group's current Debt-to-EBITDA is 1.96, which is near median its own 10-year median of 1.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is UnitedHealth Group stock overvalued right now?
Based on GuruFocus' analysis, UnitedHealth Group (UNH) is currently considered Significantly Undervalued. The stock's GF Value™ is $604.56, compared to a current price of $417.73 — trading 30.9% below its estimated fair value. The current Debt-to-EBITDA is 1.96, which is near median its 10-year median of 1.82 and 44.3% below the Healthcare Plans industry median of 3.52. UnitedHealth Group's overall GF Score™ is 78/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For UnitedHealth Group (UNH), the current Debt-to-EBITDA is 1.96 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is UnitedHealth Group (UNH) Overvalued in 2026?
Based on GuruFocus' analysis, UnitedHealth Group stock appears to be undervalued.
The current stock price of $417.73 is trading 30.9% below its estimated GF Value™ of $604.56.
GuruFocus considers UnitedHealth Group to be Significantly Undervalued.
Key valuation signals for UNH:
Debt-to-EBITDA: 1.96 (near median its 10-year median of 1.82)
GF Value™: $604.56 vs. price of $417.73 (30.9% below fair value)
Industry Position: 44.3% below the Healthcare Plans median (#6 of 13)
No single metric tells the full story. See the UNH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
UnitedHealth Group is one of the largest private health insurers and provides medical benefits to about 51 million members globally, including 1 million outside the US as of December 2025. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in medical insurance. Along with its insurance assets, UnitedHealth's Optum franchises help create a healthcare services colossus that spans everything from pharmaceutical benefits to providing outpatient care and analytics to affiliates and third parties.
78GF Score
Get the complete analysis for UNH
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
UNH has been successfully added to your 
